Navigation Links
Media Advisory - Bioniche Discusses USDA Comment on E. coli O157:H7 Cattle Vaccine Field Trial
Date:10/5/2007

-- conference call and audio web cast on October 9, 2007 --

BELLEVILLE, ON, Oct. 5 /PRNewswire-FirstCall/ - Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company (TSX:BNC), will be discussing the U.S. Department of Agriculture (USDA) comment on a field trial for its E. coli O157:H7 cattle vaccine during a:

Conference Call & Audio Web Cast

Tuesday, October 9, 2007

9:00 a.m. (Eastern)

To participate in the teleconference, call 416-644-3414/toll-free 1-800-733-7571.

A listen-only audio web cast will be available at:

http://www.newswire.ca/en/webcast/viewEvent.cgi?eventID=2039180 (English)

http://www.cnw.ca/fr/webcast/viewEvent.cgi?eventID=2039180 (French)

A replay of the conference call will be available until October 16, 2007 by calling (416) 640-1917 or toll-free 1-877-289-8525 (passcode: 21249516 followed by the number sign).

The web cast will be available for replay using the above links until January 9, 2008.

About Bioniche Life Sciences

Bioniche Life Sciences Inc. is a research-based, technology-driven Canadian biopharmaceutical company focused on the discovery, development, manufacturing, and marketing of proprietary products for human and animal health markets worldwide. The fully-integrated company employs approximately 195 skilled personnel and has three operating divisions: Human Health, Animal Health, and Food Safety. The Company's primary goal is to develop proprietary cancer therapies supported by revenues from marketed products in human and animal health. For more information, please visit http://www.Bioniche.com.


'/>"/>
SOURCE Bioniche Life Sciences Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Indian Minister wanted Media to Propaganda HIV/AIDS awareness
2. Scientist Calls Upon Media To Retract His Work
3. Rabies Requires Immediate Treatment
4. Media Messages Can Serve To Reduce Smoking Indoors
5. Media Plays Crucial Role In Flu Vaccinations
6. Chronic shortage of GPs in Australia, Need for Immediate Intervention
7. Substance Abuse Prevention Messages Better Received Among Teenagers in the Form of Media Campaigns and Curriculum
8. Medias Plays Vital Role In Sexual Behavior Of Teenagers
9. Immediate Attention Is Needed To Tackle the Obesity Crisis among Children
10. Long Term Mediation Not Advisable To Treat Hot Flashes
11. PharmaVentures Exploits Fastest Growing Media Channel to Launch First Pharmaceutical Business Television Show
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... 05, 2016 , ... As renowned, board-certified dermatologists, Dr. Sabrina G. Fabi and ... who do not do their research and undergo cosmetic dermatology treatments from unqualified practitioners ... of a renaissance and every other month a new treatment or device is launched, ...
(Date:12/5/2016)... , ... December 05, 2016 , ... ... called the CardioQuick Patch® significantly improves the reproducibility and accuracy of placing precordial ... healthcare settings. , Over the last 60 years, studies have shown that ...
(Date:12/4/2016)... ... 03, 2016 , ... While James Earl Jones is known for myriad roles ... show called "Front Page". One of the forthcoming episodes examines mammogram techniques; a very ... in large part due to early detection. Like any other disease, treatments have a ...
(Date:12/4/2016)... CA (PRWEB) , ... December 04, 2016 , ... ... without undergoing major cosmetic surgery can now take advantage of a cosmetic procedure ... advanced skin rejuvenation treatment that reduces the appearance of age spots, fine ...
(Date:12/2/2016)... ... ... Lori G. Cohen and Sara K. Thompson , shareholders in ... Conference Institute’s 21st Drug & Medical Device Litigation Conference , taking place in New ... Cohen, who chairs the firm’s Pharmaceutical, Medical Device & Health Care Litigation Practice and ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)... innovative, personalized cell-based treatment for a high-risk form of the most common ... Hospital of Philadelphia today reported new results using ... The physician-scientists presented findings at the annual meeting of the American ... Continue Reading ... ...
(Date:12/2/2016)... , Dec 2, 2016 Research and Markets ... newsletter to their offering. ... , , R&D Drug ... Publishing,s proprietary R&D Drug Pipeline Database provides 24/7 online access to ... on the market and on investigational drug candidates in research & ...
(Date:12/2/2016)... Columbia , December 2, 2016 - bioLytical lanza el ... nuevas directrices de la OMS     Continue Reading ... ... , , ... enfermedades infecciosas, ha anunciado hoy que está expandiendo el lanzamiento de su INSTI ...
Breaking Medicine Technology: